HCPCS Level IIdrugActive
J9184
Inj gemcitabin (avyxa) 200mg
BETOS: O1D
Effective: 2026-01-01
Description
Injection, gemcitabine hydrochloride (avyxa), 200 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Avgesmi
Manufacturer
Avyxa Pharma, LLC
HCPCS Dosage
200 MG
Billing Units
1.0000
3
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.